Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Edding Genor Group HoldingsHKSE:06998 +0.33%15 Gross Margin % is 68.15% as of Dec. 2025, which is 1% above its 10-year median of 67.78. GuruFocus rates HKSE:06998 with a GF Score™ of 15/100. The stock has 1 warning sign investors should review. Among 939 Drug Manufacturers companies, Edding Genor Group Holdings ranks better than 79.87% on this metric.
HKSE:06998's Gross Margin % is ranked better than 79.87% of 939
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs HKSE:06998: 68.15
Edding Genor Group Holdings had a gross margin of 68.15% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Edding Genor Group Holdings (HKSE:06998) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Edding Genor Group Holdings had a gross margin of 68.15% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Edding Genor Group Holdings Gross Margin % Related Terms
Edding Genor Group Holdings Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Edding Genor Group Holdings Gross Margin % Chart
Edding Genor Group Holdings Annual Data
Trend
Dec24
Dec25
Gross Margin %
67.41
68.15
Edding Genor Group Holdings Semi-Annual Data
Dec24
Dec25
Gross Margin %
67.41
68.15
HKSE:06998 vs ZTS: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Edding Genor Group Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Edding Genor Group Holdings Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Edding Genor Group Holdings's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Edding Genor Group Holdings's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Edding Genor Group Holdings (HKSE:06998) has a Gross Margin % of 68.15% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Edding Genor Group Holdings and its competitors. This is near median its historical median of 67.78. Over the past decade, Edding Genor Group Holdings' Gross Margin % has ranged from 67.41 to 68.15. According to the industry distribution chart, Edding Genor Group Holdings ranks #189 out of 939 companies in the Drug Manufacturers industry, placing it in the top 20.1%.
Is Edding Genor Group Holdings' Gross Margin % too high?
Edding Genor Group Holdings' current Gross Margin % of 68.15% is near median its 10-year median of 67.78. Over the past 10 years, this metric has ranged from a low of 67.41 to a high of 68.15. The Drug Manufacturers industry median Gross Margin % is 48.54. Edding Genor Group Holdings' value of 68.15% is 40.4% above this industry median. Based on the distribution chart, Edding Genor Group Holdings ranks #189 out of 939 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Edding Genor Group Holdings has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Edding Genor Group Holdings' Gross Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Edding Genor Group Holdings ranks #189 out of 939 companies for Gross Margin %. This places Edding Genor Group Holdings in the top 20% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 48.54. Edding Genor Group Holdings' value of 68.15% is 40.4% above this benchmark. Historically, Edding Genor Group Holdings' own Gross Margin % has ranged from 67.41 to 68.15 over the past decade. While the company's 10-year median is 67.78 vs. the industry median of 48.54, Edding Genor Group Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 939 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Edding Genor Group Holdings's current Gross Margin % of 68.15% is 40.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Edding Genor Group Holdings and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Edding Genor Group Holdings's current Gross Margin % is 68.15%, which is near median its own 10-year median of 67.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Edding Genor Group Holdings stock overvalued right now?
Edding Genor Group Holdings (HKSE:06998) has a current Gross Margin % of 68.15%. The current Gross Margin % is 68.15%, which is near median its 10-year median of 67.78 and 40.4% above the Drug Manufacturers industry median of 48.54. Edding Genor Group Holdings' overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Edding Genor Group Holdings (HKSE:06998), the current Gross Margin % is 68.15% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Edding Genor Group Holdings Ltd is an integrated specialty biopharmaceutical company, focusing on oncology, autoimmune diseases, cardiovascular diseases, respiratory diseases, and anti-infectives. Through the acquisition of branded drug assets from multinational pharmaceutical companies (MNCs) and licensing in development and commercialisation rights of patented drugs from international biopharmaceutical companies, it has established a portfolio of originator-branded and other drugs. The company has two reportable operating segments: Manufacturing and Distribution, which generates the maximum revenue, and Research and development. Geographically, it derives maximum revenue from the Chinese mainland, and the rest from the USA and other markets.
15GF Score
Get the complete analysis for HKSE:06998
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06998 has been successfully added to your 
